These include MLL-rearranged and hyperdiploid B-ALL, where FLT3 mutations occur in approximately 2–22% of cases, as well as early T-cell precursor (ETP) ALL, in which rates as high as 37.5% have been reported in small adult cohorts [29]. This evidence concerns the gene FLT3 and acute lymphoblastic leukemia.